
Biocon Investor Relations Material
Latest events

Q4 24/25
Biocon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biocon Ltd
Access all reports
Biocon Limited operates through Biologics, Branded Formulations, and Research Services segments. The Biologics segment sells pharmaceutical products and services to regulated markets, including India and United States; the India market through alliance partners and sale of clinical trial material; various countries in Asia Pacific and Middle East and Africa through alliance partners; and the Europe market through its subsidiary Biocon Norway. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Key slides for Biocon Ltd


Q3 24/25
Biocon Ltd


Q2 24/25
Biocon Ltd
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BIOCON
Country
🇮🇳 India